2020 年第一季度报告 公司代码：600278 公司简称：东方创业 东方国际创业股份有限公司 2020 年第一季度报告 1 / 22 2020 年第一季度报告 一、 二、 11Í 四、 | --- | |----------------| | 目录 | | 重要提示 . | | 公司基本情况 . | | 重要事项 . | | 附录 . | 2 / 22 2020 年第一季度报告 单位：元 币种：人民币 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人季胜君、主管会计工作负责人瞿元庆及会计机构负责人（会计主管人员）周显枫 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第一季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 | --- | --- | --- | --- | --- | |-------------------------------------------------|------- ...

2019 年年度报告 公司代码：600278 公司简称：东方创业 东方国际创业股份有限公司 2019 年年度报告 1 / 235 2019 年年度报告 。 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 (一) 天职国际会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 三、 公司负责人季胜君、主管会计工作负责人瞿元庆及会计机构负责人（会计主管人员）周显枫 声明：保证年度报告中财务报告的真实、准确、完整。 四、 经董事会审议的报告期利润分配预案或公积金转增股本预案 2019年度公司拟以总股本522,241,739股为基数，向全体股东每10股派现金红利0.65 元（含税） ，共计派现金红利33,945,713.04元，剩余795,306,581.21元，结转以后年度分配。 五、 前瞻性陈述的风险声明 √适用 □不适用 本报告涉及的未来计划等前瞻性陈述，不构成公司对投资者的实质承诺，请投资者注意投资风险 六、 是否存在被控股股东及其关联方非经 ...

2019 年第三季度报告 公司代码：600278 公司简称：东方创业 东方国际创业股份有限公司 2019 年第三季度报告 1 / 23 2019 年第三季度报告 一、 重要提示 二、 公司基本情况. 11[ 重要事项 四、 附录 目录 2 / 23 2019 年第三季度报告 单位：元 币种：人民币 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人季胜君、主管会计工作负责人瞿元庆及会计机构负责人（会计主管人员）周显枫 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 | --- | --- | --- | --- | |----------------------------------------------|------------------------------|------------------------------------|-- ...

2019 年半年度报告 公司代码：600278 公司简称：东方创业 东方国际创业股份有限公司 2019 年半年度报告 1 / 160 2019 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实、准确、完 整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 未出席董事情况 | --- | --- | --- | --- | |----------------|----------------|----------------------|--------------| | 未出席董事职务 | 未出席董事姓名 | 未出席董事的原因说明 | 被委托人姓名 | | 董事 | 王佳 | 出差 | 季胜君 | | 董事 | 朱继东 | 出差 | 邢建华 | | 独立董事 | 黄真诚 | 出差 | 史敏 | 三、 本半年度报告未经审计。 四、 公司负责人季胜君、主管会计工作负责人瞿元庆及会计机构负责人（会计主管人员）周显枫 声明：保证半年度报告中财务报告的真实、准确、完整。 五、 经董事会审议的报告期利润分配预案或公积金转增股本预案 不适用 六、 ...

2019 年第一季度报告 公司代码：600278 公司简称：东方创业 东方国际创业股份有限公司 2019 年第一季度报告 1 / 28 2019 年第一季度报告 í 二、 11Í 四、 目录 | --- | |----------------| | | | 重要提示 . | | 公司基本情况 . | | 重要事项 . | | 附录 . | 2 / 28 2019 年第一季度报告 单位：元 币种：人民币 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人季胜君、主管会计工作负责人瞿元庆及会计机构负责人（会计主管人员）周显枫 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第一季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 | --- | --- | --- | --- | |-------------------------------------------------|-------------- ...

2018 年年度报告 公司代码：600278 公司简称：东方创业 东方国际创业股份有限公司 2018 年年度报告 1 / 206 2018 年年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 天职国际会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、 公司负责人季胜君、主管会计工作负责人瞿元庆及会计机构负责人（会计主管人员）周显枫 声明：保证年度报告中财务报告的真实、准确、完整。 五、 经董事会审议的报告期利润分配预案或公积金转增股本预案 2018年度公司拟以总股本522,241,739股为基数，向全体股东每10股派现金红利0.90 元（含税） ，共计派现金红利47，001，756.51元，剩余770,214,405.58元，结转以后年度分配。 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告涉及的未来计划等前瞻性陈述，不构成公司对投资者的实质承诺，请投资者注意投资风险 。 七、 是否存在被控股股东及其关联方非经营 ...

Financial Performance - Operating revenue increased by 11.76% to CNY 12,761,346,129.88 for the period from January to September[6] - Net profit attributable to shareholders decreased by 1.53% to CNY 103,986,126.64 for the same period[6] - Net profit attributable to shareholders after deducting non-recurring gains and losses increased by 87.67% to CNY 67,523,503.50[6] - Total operating revenue for Q3 2018 reached ¥4,325,826,454.96, an increase of 7.2% compared to ¥4,035,484,366.84 in Q3 2017[34] - Net profit for the first nine months of 2018 was ¥12,761,346,129.88, compared to ¥11,418,900,157.84 for the same period in 2017, indicating a growth of 11.8%[34] - The net profit for Q3 2018 reached ¥48,450,496.24, up 63.9% from ¥29,545,881.24 in the same period last year[35] - The total profit for Q3 2018 was ¥66,155,403.55, compared to ¥46,093,370.49 in Q3 2017, reflecting a growth of 43.6%[35] Asset and Liability Changes - Total assets decreased by 8.13% to CNY 7,841,132,161.39 compared to the end of the previous year[6] - Net assets attributable to shareholders decreased by 9.06% to CNY 3,701,109,480.26 compared to the end of the previous year[6] - The company's total liabilities were RMB 3,867,051,834.57, down from RMB 4,174,125,441.47, indicating a reduction of about 7.4%[27] - The company's total equity was RMB 3,974,080,326.82, down from RMB 4,361,170,134.28, reflecting a decline of about 8.8%[27] - Total assets as of September 30, 2018, amounted to ¥4,294,082,874.44, down from ¥4,927,208,135.86 at the beginning of the year, a decrease of 12.9%[32] - Total liabilities decreased to ¥889,327,591.07 from ¥1,074,612,587.80, representing a reduction of 17.2%[32] Cash Flow Analysis - Net cash flow from operating activities decreased by 62.79% to CNY -359,465,080.25 due to cash payments related to the expiration of import business contracts[7] - Cash flow from operating activities decreased by 62.79% year-on-year, mainly due to cash payments related to expired import contracts by a subsidiary[16] - Cash inflow from operating activities for the first nine months of 2018 was 4,044,338,509.76 RMB, down from 13,619,391,864.30 RMB year-on-year[43] - Cash inflow from investment activities was 5,638,106,200.34 RMB, while cash outflow was 5,919,140,793.56 RMB, resulting in a net cash flow of -281,034,593.22 RMB[43] - Total cash outflow from financing activities was 472,871,280.56 RMB, leading to a net cash flow of -157,040,004.16 RMB[44] Shareholder Information - The top shareholder, Oriental International (Group) Co., Ltd., holds 67.46% of the shares[11] - The company reported a total of 352,312,948 shares held by its largest shareholder[11] Expense and Income Changes - Tax and additional fees increased by 47.82% year-on-year, primarily due to the growth in foreign trade sales[12] - Financial expenses decreased by 162.16% year-on-year, mainly due to increased exchange gains from fluctuations in the US dollar[12] - Asset impairment losses increased by 305.53% year-on-year, attributed to the provision for bad debts in line with accounting standards due to business expansion[12] - Investment income decreased by 44.26% year-on-year, as the company did not dispose of available-for-sale financial assets during the reporting period[12] - The company's total comprehensive income for Q3 2018 was -¥75,458,842.32, a significant decrease from ¥904,116,207.63 in Q3 2017[36] Inventory and Receivables - Accounts receivable increased by 35.67% compared to the beginning of the period, reflecting growth in sales scale[14] - Inventory increased by 45.34% compared to the beginning of the period, due to increased stocking by a subsidiary[14] - The company's inventory increased to RMB 625,876,876.46 from RMB 430,638,795.04, showing a growth of about 45.2%[25] Future Plans and Commitments - The company plans to issue exchangeable bonds not exceeding RMB 500 million, with the application materials submitted for review[18] - The company has committed to addressing potential liabilities related to ongoing litigation and arbitration, with a focus on maintaining financial stability[22] - The company is actively promoting the external trade company to resolve historical debt disputes and meet relevant conditions for asset injection[21] - The company aims to implement asset restructuring in accordance with market fair prices and regulatory requirements[21]

Financial Performance - The company's operating revenue for the first half of 2018 was approximately CNY 8.44 billion, representing a 14.25% increase compared to CNY 7.38 billion in the same period last year[18]. - The net profit attributable to shareholders decreased by 10.19% to CNY 71.69 million from CNY 79.83 million year-on-year[18]. - Basic earnings per share fell by 6.67% to CNY 0.14 from CNY 0.15 in the same period last year[20]. - The weighted average return on equity decreased by 0.53 percentage points to 1.81% from 2.34% year-on-year[20]. - The net profit attributable to the parent company for the first half of 2018 was 38.15 million yuan, with a significant increase in net export business scale by 19.60% year-on-year[30]. - The company reported a net cash flow from operating activities of -439.29 million yuan, a decrease of 108.66% compared to -210.52 million yuan in the previous year[34]. - The company reported a total comprehensive income of -277.46 million RMB for the first half of 2018, compared to 752.97 million RMB in the previous year[85]. - The net profit for the first half of 2018 was ¥89,040,713.75, a decrease of 8.5% from ¥97,014,593.84 in the previous year[82]. Assets and Liabilities - The total assets decreased by 10.29% to CNY 7.66 billion from CNY 8.54 billion at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 5.52% to CNY 3.84 billion compared to CNY 4.07 billion at the end of the previous year[19]. - Cash and cash equivalents decreased by 32.58% to ¥1,829,073,383.96, primarily due to the expiration of import contracts by a subsidiary[37]. - Accounts receivable increased by 39.21% to ¥931,495,030.80, reflecting overall sales growth[37]. - Total liabilities decreased to ¥3,552,318,348.54 from ¥4,174,125,441.47, a reduction of about 14.9%[76]. - The company's equity attributable to shareholders decreased to ¥3,844,947,098.72 from ¥4,069,715,317.07, reflecting a decline of approximately 5.5%[76]. Cash Flow - The net cash flow from operating activities showed a significant decline of 108.66%, resulting in a negative cash flow of CNY 439.29 million, primarily due to cash payments related to the expiration of import business contracts[20]. - Cash inflow from investment activities was 4.41 billion RMB, compared to 2.77 billion RMB in the previous year, indicating a significant increase of approximately 59%[88]. - Cash outflow from financing activities totaled 420.60 million RMB, up from 225.24 million RMB in the previous year, reflecting an increase of about 86.5%[89]. Strategic Initiatives - The company established a venture capital fund focused on investing in innovative medical enterprises, indicating a strategic shift towards the healthcare sector[31]. - The company plans to issue exchangeable bonds to support business development, reflecting ongoing efforts to optimize capital structure[31]. - The company aims to enhance its supply chain management capabilities by integrating trade, logistics, capital, and management[28]. Subsidiaries and Investments - The company holds a 100% equity stake in Dongfang International Group, which has a net asset value of CNY 16.25 million and a net profit of CNY 178.48 thousand[43]. - The total investment cost for Huazheng Securities (SH.600909) is CNY 320.71 million, with a year-end book value of CNY 1.37 billion[41]. - The company has reported a significant decrease in net profit for several subsidiaries, indicating potential areas for strategic improvement[45]. Risk Management - The company is facing economic risks due to slowing domestic growth and high export costs, with potential impacts from US-China trade tensions[47]. - Customer credit risk is managed through strict credit investigations and export credit insurance for key clients, reducing exposure[48]. - The company maintains ample liquidity and strong relationships with financial institutions, effectively managing financial risks[49]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 28,425[66]. - The largest shareholder, Oriental International (Group) Co., Ltd., holds 67.46% of the shares, totaling 352,312,948 shares[67]. - The company reported a profit distribution of ¥31,642,970.00 to shareholders during the period[96]. Accounting and Compliance - The financial statements are prepared in accordance with the latest enterprise accounting standards, reflecting the company's financial position, operating results, and cash flows accurately[115]. - The company has not disclosed any significant changes in accounting policies or estimates during the reporting period[63]. - There were no major accounting errors that required restatement in the reporting period[63]. Market Position - The company has a strong market position with a well-established sales network, mitigating industry risks in international trade and logistics[48]. - The depreciation of the RMB against the USD since May 2018 has positively impacted export operations, enhancing profitability[49].

Financial Performance - The company's operating revenue for the first quarter of 2018 was CNY 4,607,039,582.96, representing a 27.15% increase compared to the same period last year[5] - The net profit attributable to shareholders of the listed company was CNY 50,562,197.44, an increase of 16.99% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 91.60% to CNY 16,594,114.91, mainly due to improved profitability in the main business[5] - Total operating revenue for Q1 2018 reached ¥4,607,039,582.96, an increase of 27.2% compared to ¥3,623,271,134.88 in the same period last year[33] - Net profit for Q1 2018 was ¥60,631,552.29, representing a 16.5% increase from ¥51,843,539.66 in Q1 2017[34] Cash Flow - The net cash flow from operating activities decreased by 120.15% to -CNY 370,697,275.76, primarily due to increased accounts payable and decreased advance receipts[5] - Cash flow from operating activities showed a net outflow of CNY 370.70 million, worsening from a net outflow of CNY 168.38 million in Q1 2017[41] - Cash inflow from operating activities totaled CNY 4.46 billion, slightly up from CNY 4.33 billion in the same period last year[40] - Cash outflow from operating activities was CNY 4.83 billion, compared to CNY 4.50 billion in Q1 2017[40] - Investment activities generated a net cash outflow of CNY 29.05 million, a significant decrease from a net inflow of CNY 33.07 million in the previous year[41] Assets and Liabilities - Total assets at the end of the reporting period were CNY 8,093,940,438.10, a decrease of 5.17% from the end of the previous year[5] - The company's total assets as of March 31, 2018, amounted to ¥4,841,147,171.68, a decrease from ¥4,927,208,135.86 at the beginning of the year[30] - The company's total liabilities decreased to CNY 3,730,144,978.53 from CNY 4,174,125,441.47, reflecting a reduction of approximately 10.63%[25] - The total liabilities decreased to ¥1,033,704,696.49 from ¥1,074,612,587.80 at the beginning of the year[30] Shareholder Information - The total number of shareholders at the end of the reporting period was 29,100[9] - The total equity attributable to shareholders of the parent company was CNY 4,067,034,992.49, slightly down from CNY 4,069,715,317.07[26] - Basic earnings per share for Q1 2018 were ¥0.10, compared to ¥0.09 in Q1 2017[35] Government Support and Other Income - The company received government subsidies amounting to CNY 3,818,146.12, which contributed to the increase in operating income[12] - The company reported a significant increase in other income, which rose by 314.21% to CNY 4,377,285.63, attributed to government subsidies received by a subsidiary[12] Investment and Financing Activities - Net cash flow from investing activities decreased by 187.84% to -¥29,047,072.04, as there were no significant asset sales in the current period compared to the previous year[16] - Net cash flow from financing activities increased by 47.62% to -¥40,464,127.00, due to reduced repayment amounts of entrusted loans to Dongfang International Group[16] - The company paid $40,000,000.00 in debt repayment during the quarter[44] Strategic Developments - The company approved a non-public stock issuance that expired in January 2018 due to market conditions[17] - Dongsong Medical received approval to list its shares on the National Equities Exchange and Quotations system, officially listing on April 24, 2018[17] - The company completed a major asset restructuring transaction, with commitments to inject quality assets into the listed company within 12 months after the issuance of new shares[20] - The company has received approval from the China Securities Regulatory Commission for its non-public offering plan, which includes the acquisition of a 100% stake in a foreign trade company[20]

Financial Performance - In 2017, the company's operating revenue reached ¥15,833,649,846.57, an increase of 1.46% compared to ¥15,605,854,992.34 in 2016[21] - The net profit attributable to shareholders was ¥173,442,386.24, representing a 16.14% increase from ¥149,334,668.41 in the previous year[21] - The total assets of the company at the end of 2017 amounted to ¥8,535,295,575.75, reflecting a 16.29% increase from ¥7,339,766,836.44 in 2016[22] - Basic earnings per share increased by 13.79% to CNY 0.33 compared to the previous year[23] - The company achieved total operating revenue of CNY 15.834 billion in 2017, with a net profit of CNY 173 million attributable to the parent company[32] - The company reported a significant decrease in net profit from non-recurring gains and losses, down 49.27% to ¥28,039,201.33 compared to ¥55,272,078.13 in 2016[22] - The company reported a net profit of 7,338.07 million CNY from Shanghai Dongsong Medical Technology Co., Ltd., contributing significantly to overall profitability[71] - The company reported a total of ¥1,967,801.27 in other securities investments, with a loss of ¥158,020.17 during the reporting period[64] Cash Flow and Investments - The company's net cash flow from operating activities decreased by 65.74% to ¥202,458,381.56 from ¥590,900,990.99 in 2016[22] - The net cash flow from operating activities decreased by 65.74% year-on-year, attributed to the absence of operational restructuring factors from the previous year[24] - The net cash flow from investment activities decreased by 85.14% compared to last year, mainly due to the purchase of two super handy bulk carriers by the wholly-owned subsidiary Xin Hai Hang Ye[57] - The company’s financial expenses rose by 224.33% year-on-year, mainly due to exchange rate fluctuations[43] - The company’s total cash inflow from operating activities was CNY 18,373,096,959.97, compared to CNY 18,015,097,746.00 in the previous year, showing a slight increase[173] - The company’s investment activities generated a total cash inflow of ¥3,464,992,284.27, a significant increase from ¥443,145,345.57 in the previous year[177] Shareholder Information - The proposed cash dividend for 2017 is ¥1.00 per 10 shares, totaling ¥52,224,173.90 to be distributed to shareholders[5] - The company has maintained a consistent cash dividend policy since its listing, aiming to provide substantial returns to shareholders[101] - The total number of ordinary shareholders reached 31,622 by the end of the reporting period, an increase from 29,530 in the previous month[108] - The controlling shareholder, Oriental International Group, reduced its shareholding from 70.16% to 67.46% after exchanging 14,100,500 shares[106] Risk Management and Compliance - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report[6] - The company has established a comprehensive risk management system to address legal risks, including a legal audit department and strict contract review processes[78] - The company has implemented strict credit investigations and dynamic risk management for important clients to mitigate credit risk[78] - The company is committed to enhancing internal control systems and employee training to mitigate various operational risks[75] Strategic Initiatives - The company is focusing on enhancing its supply chain management capabilities by integrating trade, logistics, capital, and management[35] - The company is actively developing new business areas, including health fund projects, to improve its competitive edge[72] - The company plans to enhance its core competitiveness by optimizing asset allocation and investing in modern supply chain services and the health industry[73] - The company aims to clear the foreign trade company's debt disputes within 30 months after the transaction completion, enhancing internal controls to reduce business risks[83] Subsidiaries and Market Presence - The company has invested in the health industry, with its subsidiary Dongsong completing a shareholding reform and preparing for a new third board listing[33] - The company’s subsidiary, Oriental International Logistics, achieved a net profit of 3,283.91 million CNY, highlighting its strong performance in the logistics sector[71] - The company has established a significant presence in e-commerce through Shanghai Lingxiu E-commerce Co., Ltd., with a 66.94% ownership[195] Corporate Governance - The financial report was approved by the board of directors on March 30, 2018, indicating a commitment to transparency and governance[194] - The board of directors held a total of 13 meetings during the year, with 5 conducted in person and 8 via communication methods[140] - The company has maintained compliance with the Company Law and relevant regulations from the China Securities Regulatory Commission[136] Employee and Director Compensation - The total remuneration paid to all directors, supervisors, and senior management at the end of the reporting period amounted to 3.283 million yuan[128] - The total pre-tax compensation for the chairman, Lv Yongming, was 81.03 million CNY for the reporting period[121] - The independent directors' remuneration was set at 80,000 yuan per year (pre-tax), distributed monthly, effective for the term of the seventh board of directors[128] Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 12%[123] - The company plans to continue investing in new product development and market expansion strategies to drive future growth[186] - The company aims to improve its risk management strategies, as indicated by the allocation of 25,831,019.3 RMB to general risk reserves[185]